» Download Public Reports
About 300 reports
- Country report
- November 2012
- 69 pages
... Biotechnology coordination committee (sbcc) District level committee (dlc) Food regulatory authority of india To monitor and trace the gm foods Labeling for consumer choice and citizen rights ...
December 2012
... To accelerate growth of all our business verticals. Going forward we aim to have higher contribution from biosimilars, research services and branded formulations to the overall revenue. Our increasing r ...
February 2013
... Will not fall under the regulatory regimen) as the european regulatory system for crop biotechnology has been changing, new requirements have been added and their applications have been extended to new ...
February 2013
... Disease science & biotechnology Infectious science & biotechnology institute in north east (linking to thsti as partner for training & education) Automated high-throughput dna sequencing facilities ...
February 2013
... Such as via campesina, the food sovereignty movement, the un special rapporteur on the right to food and pingos in both the south and the north. The attempt to persuade udcs to accept and adopt gm foods ...
March 2013
... Means more competition more competition means lesser price to patients lesser price is sigh-of-relief for patients benefit of biosimilar evolution in india product pre-1995 current hepatitis b ...
March 2013
... Accounts for 10% of the global scenario [29]. The demand of diagnostic and therapeutic enzymes is expected to increase owing to improvement in medical care facilities in developing countries and global ...
» Purchase Premium Reports
(From $ 250 - $ 2 000)
58 reports
- $ 2 064
- Industry report
- May 2013
- by La Merie Publishing
Product Description The new Competitive Intelligence Report Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors of May 2013 provides a competitor analysis of the product portfolios and development ...
February 2013
$ 600
India is witnessing an accelerating shift towards the prevalence of non-communicable diseases, having secured third position in congenital malformations and genetic disorders as the commonest causes of ...
April 2013
$ 500
Stem Cell Banking has emerged as new opportunity of healthcare services provider in Indian market. The market is still in nascent stage of development and valued at more than INR 400 Crore (US$ 70 Million) ...
April 2013
$ 516
Product description The present Competitive Intelligence Report about G-CSF and GM-CSF product portfolios and R&D pipelines provides a competitor evaluation in the field of G-CSF & GM-CSF branded products ...
March 2013
$ 300
This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...
April 2013
$ 250
Summary Avesthagen Limited (Avesthagen) is a life science company, based in India. The company provides personalized healthcare through convergence of food, pharma and population genetics. Its business ...
March 2013
$ 250
Summary International Stem Cell Corporation (International Stem Cell) is a biotechnology company, based in the US. The company develops therapeutic products and research products. It develops a stem cell ...